Research and development in Parkinson’s disease

Today more than 40 novel drugs are in development for Parkinson’s disease and related disorders. We continually assess and appraise this evolving drug development activity.

Our database of R&D activity is updated on an ongoing basis and empowers our provison of services to the biopharmaceutical and financial communities.


We work with our clients to deliver a range of Parkinson’s related contract research and consultancy services that are tailored to their individual requirements in terms of science, timelines and cost.

Atuka provides services in three broad categories

Learn more »

About Us - Parkinson's Research

Atuka provides contract research and consultancy services for the biopharmaceutical industry to aid the development of novel therapeutics and diagnostics for Parkinson's disease.

In addition to conducting fee-for-service pre-clinical and clinical research, we continually assess and appraise evolving drug development activity for Parkinson's disease and related disorders.

Atuka was founded in 2003 and incorporated in 2011. We operate over multiple sites in Canada and China.

Learn more »